Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brain Health Alliance (BHA) is a non-profit research and technology organization dedicated to improving the diagnosis and treatment of brain-related disorders through advanced digital health solutions. The organization specializes in leveraging quantitative medical imaging, artificial intelligence, and machine learning to develop objective biomarkers for conditions such as Alzheimer's disease, traumatic brain injury, and epilepsy. BHA collaborates extensively with academic institutions, notably UCLA, to bridge the gap between laboratory research and clinical application. Their work focuses on providing clinicians with decision-support tools that integrate multi-modal data for personalized neurological care. By emphasizing quantitative measures of brain health, the alliance aims to facilitate earlier intervention and more precise monitoring of disease progression.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brain Health Alliance.